Literature DB >> 22679631

[Evidence for the use of modern irradiation techniques for non-small cell lung cancer: unnecessary, inadequate, insufficient or too late?].

M Guckenberger1.   

Abstract

Entities:  

Year:  2012        PMID： 22679631     DOI： 10.1007/s00066-011-0068-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  8 in total

1.  Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis.

Authors:  David Palma; Otto Visser; Frank J Lagerwaard; Jose Belderbos; Ben J Slotman; Suresh Senan
Journal:  J Clin Oncol       Date:  2010-11-01       Impact factor: 44.544

Review 2.  Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies.

Authors:  Liv Veldeman; Indira Madani; Frank Hulstaert; Gert De Meerleer; Marc Mareel; Wilfried De Neve
Journal:  Lancet Oncol       Date:  2008-04       Impact factor: 41.316

3.  Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study.

Authors:  Pierre Fournel; Gilles Robinet; Pascal Thomas; Pierre-Jean Souquet; Hervé Léna; Alain Vergnenégre; Jean-Yves Delhoume; Jacques Le Treut; Jules-Antoine Silvani; Eric Dansin; Marie-Cécile Bozonnat; Jean-Pierre Daurés; Françoise Mornex; Maurice Pérol
Journal:  J Clin Oncol       Date:  2005-08-08       Impact factor: 44.544

Review 4.  Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

Authors:  Anne Aupérin; Cecile Le Péchoux; Estelle Rolland; Walter J Curran; Kiyoyuki Furuse; Pierre Fournel; Jose Belderbos; Gerald Clamon; Hakki Cuneyt Ulutin; Rebecca Paulus; Takeharu Yamanaka; Marie-Cecile Bozonnat; Apollonia Uitterhoeve; Xiaofei Wang; Lesley Stewart; Rodrigo Arriagada; Sarah Burdett; Jean-Pierre Pignon
Journal:  J Clin Oncol       Date:  2010-03-29       Impact factor: 44.544

5.  Cost implications of the rapid adoption of newer technologies for treating prostate cancer.

Authors:  Paul L Nguyen; Xiangmei Gu; Stuart R Lipsitz; Toni K Choueiri; Wesley W Choi; Yin Lei; Karen E Hoffman; Jim C Hu
Journal:  J Clin Oncol       Date:  2011-03-14       Impact factor: 44.544

6.  Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973).

Authors:  José Belderbos; Lon Uitterhoeve; Nico van Zandwijk; Huub Belderbos; Patrick Rodrigus; Paul van de Vaart; Allan Price; Nico van Walree; Catherine Legrand; Sonia Dussenne; Harry Bartelink; Giuseppe Giaccone; Caro Koning
Journal:  Eur J Cancer       Date:  2006-11-03       Impact factor: 9.162

7.  Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey.

Authors:  Daniel Morgensztern; Shean Huey Ng; Feng Gao; Ramaswamy Govindan
Journal:  J Thorac Oncol       Date:  2010-01       Impact factor: 15.609

8.  Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.

Authors:  Michael Henke; Roland Laszig; Christian Rübe; Ulrich Schäfer; Klaus-Dieter Haase; Burkhard Schilcher; Stephan Mose; Karl T Beer; Ulrich Burger; Chris Dougherty; Hermann Frommhold
Journal:  Lancet       Date:  2003-10-18       Impact factor: 79.321
  8 in total
  1 in total

1.  DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.

Authors:  Karl Wurstbauer; Heinz Deutschmann; Karin Dagn; Peter Kopp; Franz Zehentmayr; Bernd Lamprecht; Peter Porsch; Birgit Wegleitner; Michael Studnicka; Felix Sedlmayer
Journal:  Radiat Oncol       Date:  2013-03-05       Impact factor: 3.481
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.